Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

3.2K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.2K
Signs of Puberty01:27

Signs of Puberty

2.1K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

799
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
799
Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

3.5K
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of surgical retreatment following Rezūm water vapor therapy: a multi-center real-world cohort study.

World journal of urology·2026
Same author

Outcomes of Rezūm therapy in young men: A multi-center study.

Urologia·2026
Same author

Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence.

Nature reviews. Urology·2026
Same author

Healthcare disparities and pelvic organ prolapse operative complications: a nationwide analysis.

Gynecology and pelvic medicine·2026
Same author

Health Care Sustainability: Strategies for Operating Rooms and Urogynecologic Procedures.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Aquablation versus AEEP for BPH: technique, outcomes, and the evolving surgical landscape - an EAU endourology perspective.

World journal of urology·2026
Same journal

Molecular mechanisms of erectile dysfunction in type 1 and type 2 diabetic rats: a multiomics approach.

Asian journal of andrology·2026
Same journal

The long (GGN)n repeat tract in the androgen receptor gene exerts a negative effect on quantitative sperm parameters.

Asian journal of andrology·2026
Same journal

Exploring potential targets and mechanisms of male reproductive toxicity induced by the emerging PFAS GenX and F-53B via network toxicology, molecular docking, and in vivo validation.

Asian journal of andrology·2026
Same journal

Modifiable key factors and semen quality in men undergoing preconception evaluation: a cross-sectional study.

Asian journal of andrology·2026
Same journal

Somatic cell reprogramming into stem cells: approaches, mechanisms, and therapeutic applications.

Asian journal of andrology·2026
Same journal

A homozygous splicing mutation in CCDC39 caused multiple morphological abnormalities of the flagella in an infertile man with primary ciliary dyskinesia.

Asian journal of andrology·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.7K

Testosterone and benign prostatic hyperplasia.

Thomas R Jarvis, Bilal Chughtai1, Steven A Kaplan

  • 1Department of Urology, Weill Cornell Medical College, New York, USA.

Asian Journal of Andrology
|October 23, 2014
PubMed
Summary
This summary is machine-generated.

Testosterone therapy may improve male lower urinary tract symptoms (LUTS) in some men, despite concerns about prostate health. Further research is needed to confirm these findings and understand the underlying mechanisms.

More Related Videos

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

25.0K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.6K

Related Experiment Videos

Last Updated: Apr 21, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.7K
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

25.0K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.6K

Area of Science:

  • Andrology
  • Urology
  • Endocrinology

Background:

  • Increased awareness of late-onset hypogonadism has led to greater testosterone use.
  • Concerns exist regarding testosterone's effects on the prostate and prostate cancer risk.
  • Emerging evidence suggests potential benefits for male lower urinary tract symptoms (LUTS).

Purpose of the Study:

  • To review the current evidence on testosterone's impact on LUTS in hypogonadal men.
  • To explore potential mechanisms linking testosterone, metabolic syndrome, and LUTS improvement.
  • To inform clinical practice regarding testosterone therapy for hypogonadism.

Main Methods:

  • Analysis of retrospective studies and small randomized trials.
  • Review of literature on testosterone's effects on the prostate and urinary symptoms.
  • Consideration of the role of metabolic syndrome in observed improvements.

Main Results:

  • Numerous studies indicate a potential improvement in LUTS with testosterone treatment.
  • The exact mechanism for LUTS improvement is not fully understood but may involve metabolic syndrome.
  • Current evidence is promising but lacks high-level scientific validation.

Conclusions:

  • Testosterone therapy may offer benefits for LUTS in hypogonadal men.
  • Thorough clinical evaluation is essential before initiating testosterone treatment.
  • Clinicians must counsel patients on potential risks, including urinary retention and worsening LUTS.